Double probe heat therapy could slash cervical cancer risk in HIV-Positive women

NCT ID NCT07468695

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether using two heat probes instead of one can better prevent cervical cancer in women living with HIV, who face a much higher risk. Researchers will enroll 300 women in Kenya to see if the two-probe method is safe, acceptable, and more effective at clearing HPV. If it works, this simple procedure could be a game-changer for cervical cancer prevention in low-resource settings.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
thermal ablation (heat treatment) with one or two probes
What this could lead to
If successful, this could provide a more effective way to prevent cervical cancer in women with HIV, reducing cancer rates in high-risk populations.
What could go wrong
This is an early feasibility study with only 300 participants, so results may not apply broadly. The two-probe technique might not improve outcomes and could have unknown risks.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CERVICAL PRECANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Coptic Hope Center

    Nairobi, Kenya

More trials for these conditions

Other studies related to the condition(s) this trial covers.